U.S. Tech Hardware Stock News

Maravai LifeSciences Holdings (MRVI) closed out FY 2025 with Q4 revenue of US$49.9 million and a basic EPS loss of US$0.25, alongside a trailing twelve month basic EPS loss of US$0.91 on revenue of US$185.7 million, keeping profitability squarely in focus for investors following the story. Over recent periods, quarterly revenue has ranged from US$41.6 million to US$49.9 million while basic EPS losses have moved between US$0.18 and US$0.27 per quarter, setting a clear backdrop of ongoing net...

Ambarella (AMBA) is back on investors’ radars after co‑founder, president, and CEO Fermi Wang received the inaugural 2026 IEEE Arun N. Netravali Award, highlighting the company’s work in AI‑powered video technology and edge AI semiconductor platforms. See our latest analysis for Ambarella. The recent award recognition comes as Ambarella’s share price has climbed to US$74.27, with a 30 day share price return of 45.66% and a 1 year total shareholder return of 40.56%. This suggests momentum has...

Why LandBridge Stock Is Drawing Attention Now LandBridge (LB) is catching investor interest after recent trading pressure, with the stock showing a 3.1% decline over the past day and a 6.9% pullback over the past week. Those short term moves sit alongside a one month return of a 10.4% decline and a gain of 12.8% over the past 3 months, prompting closer scrutiny of the company’s fundamentals and valuation signals. See our latest analysis for LandBridge. At a share price of US$63.97,...

National HealthCare (NHC) closed FY 2025 with fourth quarter revenue of US$386.5 million and basic EPS of US$1.60, framing a year in which trailing twelve month revenue reached about US$1.5 billion and EPS came in at US$7.76, alongside reported earnings growth of 17.7% over the past year. Over recent periods the company has seen revenue move from US$1.30 billion on a trailing twelve month basis in Q4 2024 to US$1.52 billion in Q4 2025. EPS over the same span shifted from US$6.62 to US$7.76...

Winmark Corporation recently announced that long-serving director Lawrence A. Barbetta will not stand for re-election in April 2027, while appointing Casey’s General Stores executive Stephanie S. Hoppe to its Board and key committees, in line with its independent director term-limit policy. This refresh brings fresh marketing and omnichannel retail expertise into Winmark’s boardroom, potentially influencing how the company approaches brand positioning and franchise growth decisions. Next,...

TeraWulf FY 2025: Headline Numbers and What They Signal TeraWulf (WULF) has reported FY 2025 results with fourth quarter revenue of US$35.8 million and a basic EPS loss of US$0.30, alongside net income excluding extra items of a US$126.6 million loss. This sets the tone for a year where scale and profitability are clearly still in tension. Over recent quarters, the company has seen revenue move from US$27.1 million in Q3 2024 to US$34.4 million in Q1 2025, US$47.6 million in Q2 2025, US$50.6...

Southern Copper (SCCO) is back in focus after reporting first quarter 2026 sales of US$4,251.4m and net income of US$1,576.9m, alongside fresh CEO and dividend announcements on April 23. See our latest analysis for Southern Copper. The latest news comes after a strong run, with Southern Copper's year to date share price return of 21.77% and a 1 year total shareholder return of 113.55% pointing to momentum that has cooled slightly in recent months. This includes a 9.49% 3 month share price...

Q1 2026 earnings snapshot Lee Enterprises (LEE) opened fiscal 2026 with Q1 revenue of $130.1 million and a basic EPS loss of $0.92, alongside trailing twelve month revenue of $547.8 million and a basic EPS loss of $4.34. Over recent quarters the company has seen revenue move from $144.6 million in Q1 2025 to $130.1 million in Q1 2026. Quarterly basic EPS has ranged from a loss of $2.80 to a loss of $0.31 as net income excluding extra items moved between a loss of $16.7 million and a loss of...

Conference spotlight and stock pressure set the stage Baker Hughes (BKR) heads into its Barclays Americas Select Conference appearance with the stock under pressure after a Barclays downgrade and weaker crude prices linked to expectations of a potential U.S. Iran peace agreement. See our latest analysis for Baker Hughes. Those conference headlines and the Barclays downgrade come after a sharp 7 day share price return of negative 8.8%. The stock still carries a 34.8% year to date share price...

Oshkosh (OSK) just wrapped up FY 2025 with Q4 revenue of US$2,688.8 million and basic EPS of US$2.11, supported by trailing twelve month revenue of US$10.4 billion and EPS of US$10.08. The company has seen quarterly revenue move from US$2,598.1 million in Q4 2024 to US$2,688.8 million in Q4 2025, while quarterly EPS shifted from US$2.35 to US$2.11 over the same period. This sets up a picture of steady scale with earnings that investors will be dissecting closely. With a trailing net margin of...

Xponential Fitness (XPOF) closed out FY 2025 with Q4 revenue of US$83.0 million and a basic EPS loss of US$1.17, alongside a trailing twelve month revenue base of US$314.9 million and a TTM basic EPS loss of US$1.47. Over the last six reported quarters, the company has seen quarterly revenue range from US$76.2 million to US$83.2 million while basic EPS losses have moved between US$0.01 and US$1.36. This gives investors a clearer view of how sales and per share results have interacted through...

Forward Air (FWRD) just posted its FY 2025 fourth quarter results with revenue of US$631.2 million and a basic EPS loss of US$0.91, while trailing twelve month revenue stands at US$2.5 billion against a trailing EPS loss of US$3.51 and a net loss of US$107.8 million. Over recent quarters, the company has seen quarterly revenue hold in a tight range around US$613.3 million to US$655.9 million, while quarterly EPS losses have moved between US$0.41 and US$2.59. This gives investors a clear view...

Telephone and Data Systems (TDS) has just wrapped up FY 2025 with fourth quarter revenue of US$330.7 million and basic EPS of US$0.32, alongside net income excluding extra items of US$37.2 million and earnings from discontinued operations of US$1.9 million. The company has seen quarterly revenue move from US$295.3 million in Q4 2024 to US$330.7 million in Q4 2025, while basic EPS shifted from roughly US$0.01 to US$0.32, and trailing 12 month net income excluding extra items reached US$48.2...

Wondering if Goldman Sachs Group is still reasonably priced after a strong run, or if you might be late to the party? This article focuses squarely on what the current stock price could mean for value conscious investors. The stock recently closed at US$925.87, with returns of 0.2% over 7 days, 7.1% over 30 days, 1.3% year to date, 67.1% over 1 year and 210.7% over 3 years, plus 191.0% over 5 years. This naturally raises questions about how much of the story is already reflected in the...

Teleflex stock performance and recent context Teleflex (TFX) has drawn fresh attention after recent price moves, with the stock last closing at $131.68. For investors, the key question is how current performance aligns with the underlying medical device business. See our latest analysis for Teleflex. The recent 6.9% 1 day share price return and 14.0% 30 day share price return indicate short term momentum is building, yet the 3 year total shareholder return of 45.9% decline highlights how far...

BioLife Solutions (BLFS) just closed FY 2025 with fourth quarter revenue of US$24.8 million and basic EPS of US$0.04, alongside net income from continuing operations of US$2.1 million and earnings from discontinued operations of US$9.0 million. The company has seen quarterly revenue move from US$15.1 million in Q4 2024 to US$24.8 million in Q4 2025, while basic EPS shifted from US$0.01 a year ago through losses earlier in 2025 to the latest US$0.04 print. Investors will be watching how firmly...

Upcoming earnings as the focus for Netlist (NLST) Netlist (NLST) is drawing attention after scheduling the release of its first quarter 2026 financial results before the market opens on May 12, followed by a same day earnings call. See our latest analysis for Netlist. The scheduled Q1 2026 results arrive after a period of strong momentum, with Netlist’s 30 day share price return of 81.08% and year to date share price return of 170.30%, even though the 3 year total shareholder return is a...

Founder of CNN and early Turner Broadcasting leader Ted Turner has died, marking a major moment for Warner Bros. Discovery’s CNN franchise. The death comes as CNN’s domestic audience hits new lows and Warner Bros. Discovery’s linear TV segment faces ongoing financial pressure. At the same time, the planned Paramount and Skydance combination is moving forward, drawing heightened scrutiny of foreign ownership in US media assets. For investors watching NasdaqGS:WBD, this mix of legacy and...

What recent performance says about UroGen Pharma (URGN) Without a clear single event driving headlines, UroGen Pharma (URGN) has still drawn attention after a recent share price of US$26.59 and strong moves over the past month and past 3 months. See our latest analysis for UroGen Pharma. Those sharp recent share price returns, including a 47.48% 30 day share price return and 24.54% 90 day share price return, sit on top of a 149.20% 1 year total shareholder return. This indicates that momentum...

Wendy's (WEN) just closed FY 2025 with fourth quarter revenue of US$543 million and basic EPS of US$0.14, alongside net income of US$26 million. Trailing twelve month revenue stood at about US$2.2 billion with EPS of US$0.85. Over recent quarters the company has seen quarterly revenue move from US$523 million in Q1 2025 to US$561 million in Q2 and US$550 million in Q3, with quarterly EPS ranging between US$0.20 and US$0.29 across the first three quarters. This sets up a picture where solid...

NewAmsterdam Pharma (NasdaqGM:NAMS) has wrapped up FY 2025 with fourth quarter revenue of about US$0.03 million and a quarterly loss of US$74.9 million, equal to a basic EPS loss of US$0.62. This puts a spotlight on how much cash is still going into development. The company has seen quarterly revenue range from US$0.03 million to US$19.1 million over the past four quarters, while EPS moved between a loss of US$0.15 and a loss of US$0.93, keeping margins firmly in loss making territory even as...

MP Materials (MP) has closed out FY 2025 with fourth quarter revenue of US$103.7 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$275.5 million and a trailing basic EPS loss of US$0.50. Over recent quarters the company has seen quarterly revenue move from US$60.99 million in Q4 2024 to US$103.7 million in Q4 2025, while basic EPS shifted from a loss of US$0.14 in Q4 2024 to a profit of US$0.05 in Q4 2025. This sets up a results season where investors are...

Why PDD Holdings Stock Is Back on Investors’ Radar PDD Holdings (NasdaqGS:PDD) has drawn attention after a mixed stretch in its share price, with a small move higher over the past week and month, but weaker performance year to date and over the past year. See our latest analysis for PDD Holdings. At a share price of $101.51, PDD Holdings has a slightly positive 7 day share price return of 1.63% and 30 day share price return of 1.98%. However, its year to date share price return shows a 12.30%...

BridgeBio Pharma (BBIO) closed out FY 2025 with Q4 revenue of US$154.2 million and a basic EPS loss of US$0.99, while trailing 12 month revenue stood at US$502.1 million and EPS at a loss of US$3.78. Over the past six quarters, the company has seen quarterly revenue move from US$2.7 million in Q3 2024 to US$154.2 million in Q4 2025, with basic EPS losses ranging between US$0.86 and US$1.40 over that span. This sets a clear backdrop of high revenue levels paired with ongoing losses. For...